Jeroan Allison to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications Jeroan Allison has written about Reverse Transcriptase Inhibitors.
Connection Strength
0.114
-
Willig JH, Westfall AO, Allison J, Van Wagoner N, Chang PW, Raper J, Saag MS, Mugavero MJ. Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era. Clin Infect Dis. 2007 Sep 01; 45(5):658-61.
Score: 0.072
-
McKinnell JA, Willig JH, Westfall AO, Nevin C, Allison JJ, Raper JL, Mugavero MJ, Saag MS. Antiretroviral prescribing patterns in treatment-na?ve patients in the United States. AIDS Patient Care STDS. 2010 Feb; 24(2):79-85.
Score: 0.022
-
Willig JH, Abroms S, Westfall AO, Routman J, Adusumilli S, Varshney M, Allison J, Chatham A, Raper JL, Kaslow RA, Saag MS, Mugavero MJ. Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. AIDS. 2008 Oct 01; 22(15):1951-60.
Score: 0.020